OMEPRAZOLE EXTENDED-RELEASE CAPSULES
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency has awarded DMS PHARMACEUTICAL GROUP INC under contract SPE2DP26F8169 for the supply of OMEPRAZOLE EXTENDED-RELEASE CAPSULES, identified by NSN 6505013142716 and PR 7017626560. The total contract value is $174.40, with the award date set for July 24, 2026. This delivery order is issued under the master contract SPE2DX25D9900 and constitutes a federal procurement activity under the Department of Defense. The awardee, identified by CAGE code 1UNB0, is the sole provider for this specific pharmaceutical item. The contract does not specify a set-aside type, NAICS code, or detailed performance location, and no point of contact information is provided. The transaction is accessible through the DIBBS portal via the provided UI link, reflecting the standard federal acquisition process for medical supplies.
General Info
Agency
Contract Value
$174.4NAICS
Place of Performance
Not specifiedSet-Aside
Awardee
Award Issued Date
Documents
(2)AI Contract Breakdown
Uniform Contract FormatWhat is UCF?
Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
